Repositioning Lopinavir, an HIV protease inhibitor, as a promising antifungal drug: lessons learned from Candida albicans—in silico, in vitro and in vivo approaches (2021)
- Authors:
- Autor USP: TABORDA, CARLOS PELLESCHI - ICB
- Unidade: ICB
- DOI: 10.3390/jof7060424
- Subjects: MICROBIOLOGIA; ANTIRRETROVIRAIS; INFECÇÕES POR HIV; CANDIDA ALBICANS; ENZIMAS HIDROLÍTICAS; BIOFILMES; CAMUNDONGOS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Journal of Fungi
- ISSN: 2309-608X
- Volume/Número/Paginação/Ano: v. 7, n. 6, art. 424, p. 1-33, 2021
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
SANTOS, André L. S. et al. Repositioning Lopinavir, an HIV protease inhibitor, as a promising antifungal drug: lessons learned from Candida albicans—in silico, in vitro and in vivo approaches. Journal of Fungi, v. 7, n. 6, p. 1-33, 2021Tradução . . Disponível em: https://doi.org/10.3390/jof7060424. Acesso em: 04 jun. 2024. -
APA
Santos, A. L. S., Silva, L. A. B., Gonçalves, D. de S., Ramos, L. de S., Oliveira, S. S. C., Souza, L. O. P., et al. (2021). Repositioning Lopinavir, an HIV protease inhibitor, as a promising antifungal drug: lessons learned from Candida albicans—in silico, in vitro and in vivo approaches. Journal of Fungi, 7( 6), 1-33. doi:10.3390/jof7060424 -
NLM
Santos ALS, Silva LAB, Gonçalves D de S, Ramos L de S, Oliveira SSC, Souza LOP, Oliveira VS, Lins RD, Pinto MR, Muñoz JE, Taborda CP, Branquinha MH. Repositioning Lopinavir, an HIV protease inhibitor, as a promising antifungal drug: lessons learned from Candida albicans—in silico, in vitro and in vivo approaches [Internet]. Journal of Fungi. 2021 ; 7( 6): 1-33.[citado 2024 jun. 04 ] Available from: https://doi.org/10.3390/jof7060424 -
Vancouver
Santos ALS, Silva LAB, Gonçalves D de S, Ramos L de S, Oliveira SSC, Souza LOP, Oliveira VS, Lins RD, Pinto MR, Muñoz JE, Taborda CP, Branquinha MH. Repositioning Lopinavir, an HIV protease inhibitor, as a promising antifungal drug: lessons learned from Candida albicans—in silico, in vitro and in vivo approaches [Internet]. Journal of Fungi. 2021 ; 7( 6): 1-33.[citado 2024 jun. 04 ] Available from: https://doi.org/10.3390/jof7060424 - Therapeutic DNA vaccine encoding peptide p10 against experimental paracoccidioidomycosis
- Correlation of the in vitro antifungal drug susceptibility with the in vivo activity of fluconazole in a murine model of cerebral infection caused by Cryptococcus gattii
- Binding of the wheat germ lectin to Cryptococcus neoformans chitooligomers affects multiple mechanisms required for fungal pathogenesis
- The story of Paracoccidiodes gp43
- Macrophage interaction with Paracoccidioides brasiliensis yeast cells modulates fungal metabolism and generates a response to oxidative stress
- Partial characterization of extracellular membranous vesicular structures from Paracoccidioides brasiliensis
- Radiochemical pharmacokinetic profile of P10 peptide with antifungal properties
- Monoclonal antibody to heat shock protein 60 induces a protective immune response against experimental Paracoccidioides lutzii
- Editorial: vaccines, immunotherapy and new antifungal therapyagainst fungi: updates in the new frontier
- Antifungal resistance, metabolic routes as drug targets, and new antifungal agents: an overview about endemic dimorphic fungi
Informações sobre o DOI: 10.3390/jof7060424 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 | Repositioning Lopinavir, ... | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
